REG - Eco Animal Health Gp - Posting of the Annual Report and Accounts

ECO Animal HealthAnnouncement

21/07/2023 16:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230721:nRSU8538Ga&default-theme=true

RNS Number : 8538G  Eco Animal Health Group PLC  21 July 2023

 

21 July 2023

ECO Animal Health Group pc ("ECO", the "Company" or the "Group")

(AIM: EAH)

Posting of the Annual Report and Accounts

 

ECO Animal Health Group plc, a leader in the development, registration and
marketing of pharmaceutical products for global animal health markets,
announces the publication of its Annual Report and Accounts for the year ended
31 March 2023 on the Company's website:
https://www.ecoanimalhealthgroupplc.com/investor-relations/
(https://www.ecoanimalhealthgroupplc.com/investor-relations/)

The Annual Report and Accounts will be posted today to those shareholders that
have elected to receive it by post.

A further announcement regarding the Notice of the Annual General Meeting will
be made in due course.

 

Contacts

                                                                020 8447 8899

 ECO Animal Health Group plc

 David Hallas (Chief Executive Officer)

 Christopher Wilks (Chief Financial Officer)

 IFC Advisory                                                   020 3934 6630

 Graham Herring

 Zach Cohen

 Singer Capital Markets (Nominated Adviser & Joint Broker)

 Philip Davies                                                  020 7496 3000

 George Tzimas

 Sam Butcher

 Investec (Joint Broker)

 Gary Clarence                                                  020 7597 5970

 Carlo Spingardi

 Lydia Zychowska

 

 

 Equity Development  020 7065 2692

 Hannah Crowe

 Matt Evans

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACSUAUVROUUBUAR